Vanda Pharmaceuticals (NASDAQ:VNDA) Given Buy Rating at HC Wainwright
HC Wainwright restated their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $18.00 price ...
H.C. Wainwright Keeps Their Buy Rating on Disc Medicine (IRON)
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Disc Medicine (IRON – Research Report) today and set a price target of $118.00.
H.C. Wainwright Reiterates Buy Rating on Axsome Shares
H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...
H.C. Wainwright Sticks to Their Buy Rating for Summit Therapeutics (SMMT)
In a report released on January 17, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Summit Therapeutics (SMMT – Research ...
manilatimes20h
BTCS Inc. to Participate in Fireside Chat with Blockdaemon hosted by H.C. Wainwright
BTCS Inc. (Nasdaq: BTCS) ("BTCS” or the "Company”), a leader in blockchain infrastructure and technology, is pleased to ...
Anavex Life Sciences’ (AVXL) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report issued on Tuesday morning,Benzinga reports. HC Wainwright currently has a $42.00 ...
Fintel on MSN4d
HC Wainwright & Co. Downgrades CECO Environmental (CECO)
Fintel reports that on January 17, 2025, HC Wainwright & Co. downgraded their outlook for CECO Environmental (NasdaqGS:CECO) ...
bovnews1d
H.C. Wainwright Just Reiterated Microbot Medical Inc (MBOT) Stock—What Does This Mean for Investors?
Microbot Medical Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of 51.85%. The profit margin, also known as the revenue ratio or gross profit ratio, ...
Investing5d
H.C. Wainwright maintains buy on Akero stock
On Friday, H.C. Wainwright reaffirmed its Buy rating and $50.00 price target for Akero Therapeutics (NASDAQ:AKRO), representing significant upside potential from the current trading price of $24.01.
Investing6d
H.C. Wainwright reiterates TG Therapeutics stock buy rating on growth
On Wednesday, H.C. Wainwright reaffirmed a Buy rating on shares of TG Therapeutics (NASDAQ:TGTX) shares with a steady price target of $55.00. The firm's analyst highlighted the company's strong ...
bovnews6d
Why Did H.C. Wainwright Give Gryphon Digital Mining Inc (GRYP) Stock Neutral Rating?
H.C. Wainwright has recently initiated Gryphon Digital Mining Inc (GRYP) stock to Neutral rating, as announced on July 30, 2024, according to Finviz. Earlier, on July 23, 2021, Lake Street had ...
Nasdaq13d
H.C. Wainwright cuts Jasper target, says 50% selloff overdone
H.C. Wainwright lowered the firm’s price target on Jasper Therapeutics (JSPR) to $40 from $60 and keeps a Buy rating on the shares after the company announced initial data from the BEACON study ...